Article Details

Morgan Stanley Increases Cytokinetics (NASDAQ:CYTK) Price Target to $15.00

Retrieved on: 2022-08-14 08:26:56

Tags for this article:

Click the tags to see associated articles and topics

Morgan Stanley Increases Cytokinetics (NASDAQ:CYTK) Price Target to $15.00. View article details on hiswai:

Excerpt

Morgan Stanley's target price points to a potential downside of 70.18% from the stock's previous close. Several other equities research analysts have ...

Article found on: www.defenseworld.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up